Alexandria Real Estate Equities, Inc.
Financials
Valuation Metrics
Alexandria Real Estate Equities, Inc.'s Market Cap is $9.29B. At end of 2025 it was $8.34B. Ranked #934 of 3,121 in US market (top 30%), #635 of 1,658 on NYSE (top 38%), #37 of 148 in Equity Real Estate Investment Trusts (REITs) (top 25%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $9.29B | US#934/3,121 Sec#37/148 |
| Revenue | $2.96B | US#1,211/3,121 Sec#24/148 |
| Net Income | $-904M | US—/3,121 Sec—/148 |
| Total Assets | $34.63B | US#429/3,121 Sec#13/148 |
| Net Assets | $15.55B | US#288/3,121 Sec#7/148 |
| Employees | 514 | US#2,268/3,121 Sec#46/148 |
| Value | ||
| P/B | 0.60x | US#125/3,121 Sec#23/148 |
| P/S | 3.14x | US#1,839/3,121 Sec#62/148 |
| EV/EBITDA | 51.65x | US#2,374/3,121 Sec#139/148 |
| FCF Yield | 9.44% | US#727/3,121 Sec#35/148 |
| Profitability | ||
| ROE | -5.81% | US#2,288/3,121 Sec#133/148 |
| ROA | -2.61% | US#2,422/3,121 Sec#139/148 |
| Op. Margin | -45.72% | US#2,676/3,121 Sec#140/148 |
| Revenue Growth | -2.06% | US#2,373/3,121 Sec#119/148 |
| Financial Health | ||
| Debt Ratio | 99.43% | US#1,104/3,121 Sec#47/148 |
| Total Debt | $13.17B | US#342/3,121 Sec#25/148 |
| FCF | $876M | US#640/3,121 Sec#26/148 |
| Cash | $470M | US#1,115/3,121 Sec#24/148 |
| Current Ratio | 0.11x | US#2,959/3,121 Sec#124/148 |
| Net Debt/EBITDA | 29.83x | US#2,501/3,121 Sec#139/148 |
| Dividend | ||
| Div. Yield | 7.56% | US#152/3,121 Sec#45/148 |
| Div. Growth | 2.43% | US#1,027/3,121 Sec#82/148 |
| Performance | ||
| 1Y Return | -37.19% | US#2,658/3,121 Sec#133/148 |
| 1M Return | 5.40% | US#68/3,121 Sec#1/148 |
| From 52W High | -37.26% | US#2,269/3,121 Sec#132/148 |
| 1Y MDD | -52.10% | US#2,542/3,121 Sec#142/148 |
| Trading | ||
| Volume | 2,117,127 shares | US#658/3,121 Sec#23/148 |
| Trading Value | $116M | US#614/3,121 Sec#9/148 |
| Per Share | ||
| EPS | $-5.19 | US—/3,121 Sec—/148 |
| BPS | $89.25 | US#135/3,121 Sec#2/148 |
Company Info
Alexandria Real Estate Equities, Inc. an S&P 500 company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. With our founding in 1994, Alexandria pioneered the life science real estate niche. Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative Mega campus ecosystems in AAA life science innovation cluster locations, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of December 31, 2025, Alexandria has a total market capitalization of $20.75 billion and an asset base in North America that includes 35.9 million RSF of operating properties and 3.5 million RSF of Class A/A+ properties undergoing construction. Alexandria has a long-standing and proven track record of developing Class A/A+ properties clustered in highly dynamic and collaborative Mega campus environments that enhance our tenant ability to successfully recruit and retain world-class talent and inspire productivity, efficiency, creativity, and success. Alexandria also provides strategic capital to transformative life science companies through our venture capital platform. We believe our unique business model and diligent underwriting ensure a high-quality and diverse tenant base that results in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value.